Investing

Investment Purchases

Vertex Pharmaceuticals Investment Purchases decreased by 8.5% to $1.23B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 43.0%, from $2.16B to $1.23B. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows an upward trend with a 86.5% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025

How to read this metric

An increase indicates a surplus of cash being deployed into financial markets rather than core operations; a decrease may suggest a need for liquidity.

Detailed definition

The total cash outflow for the acquisition of debt and equity securities, including marketable securities and other fina...

Peer comparison

Large-cap technology firms often show high outflows here as they manage massive cash reserves across global portfolios.

Metric ID: cf_purchases_of_investments

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$118.00M$208.30M$80.44M$117.10M$110.80M$189.90M$274.90M$1.82B$574.20M$407.20M$988.50M$2.60B$1.30B$1.38B$2.16B$1.65B$2.17B$1.35B$1.23B
QoQ Change+76.5%-61.4%+45.6%-5.4%+71.4%+44.8%+560.8%-68.4%-29.1%+142.8%+162.9%-50.1%+6.8%+55.9%-23.7%+31.9%-38.1%-8.5%
YoY Change-6.1%-8.8%+241.7%>999%+418.2%+114.4%+259.6%+43.0%+125.8%+240.0%+118.4%-36.6%+67.6%-2.8%-43.0%
Range$80.44M$2.60B
CAGR+68.4%
Avg YoY Growth+198.9%
Median YoY Growth+114.4%
Current Streak2 quarters decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's investment purchases?
Vertex Pharmaceuticals (VRTX) reported investment purchases of $1.23B in Q4 2025.
How has Vertex Pharmaceuticals's investment purchases changed year-over-year?
Vertex Pharmaceuticals's investment purchases decreased by 43.0% year-over-year, from $2.16B to $1.23B.
What is the long-term trend for Vertex Pharmaceuticals's investment purchases?
Over 4 years (2021 to 2025), Vertex Pharmaceuticals's investment purchases has grown at a 86.5% compound annual growth rate (CAGR), from $528.20M to $6.40B.
What does investment purchases mean?
The amount of money a company spent to buy stocks, bonds, or other investment securities.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.